chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Computerised tomogram thorax abnormal, Condition aggravated, Cough
Clinical narrative: Clinical Summary Patient is a 82 y.o. female with a history of severe emphysema on home O2, anxiety, and dyslipidemia with recent positive COVID test on 11/2/22 who presented to hospital 11/6/2022 with 2-4 days of increased dyspnea and cough found to have COVID-19 Pneumonia. CTPE showed patchy irregular masslike densities in lower lobes; likely inflammatory with enlarged mediastinal and bilateral hilar lymphadenopathy. Improved with steroids. Discharged to home w/ HHC 11/9/22.   1. COVID-19 Pneumonia: exposed on 10/30/22; symptom onset 11/2/22 with mildly increased dyspnea and decreased appetite; tested positive on 11/2/22 at home x 3 tests and then again at wellness center on 11/4/22. Prescribed paxlovid on 11/4/22 bt pt refused to take it. Initially very reluctant to take higher doses of prednisone, then agreed with worsening respiratory status and more SOB on 11/7/22. Given decadron for 10 day course end date 11/16/22.  2. Advanced Emphysema with Chronic Hypoxic Respiratory Failure: On 4L O2 via NC at baseline and 5mg prednisone daily. Follows with Dr. (pulmonary) and recently started on spiriva and PRN lasix. At baseline O2 requirement on admit. Continued home regimen. 3. Abnormal CT: CTPE on admit showed new patchy irregular mass-like densities in lower lobes; likely inflammatory with enlarged mediastinal and bilateral hilar lymphadenopathy. Likely due to viral infection. Repeat CT in 1 month recommended to ensure resolution of infiltrates and lymphadenopathy. Discussed findings and follow up CT with patient extensively on admit; she stated she can get in with her pulmonologist to get repeat CT.  4. Elevated Troponin: 26 on admit, downtrended to 21. EKG nonacute. Likely due to above. No further testing indicated.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dyspnoea, Electrocardiogram normal, Emphysema, Exposure to SARS-CoV-2
Clinical narrative: Clinical Summary Patient is a 82 y.o. female with a history of severe emphysema on home O2, anxiety, and dyslipidemia with recent positive COVID test on 11/2/22 who presented to hospital 11/6/2022 with 2-4 days of increased dyspnea and cough found to have COVID-19 Pneumonia. CTPE showed patchy irregular masslike densities in lower lobes; likely inflammatory with enlarged mediastinal and bilateral hilar lymphadenopathy. Improved with steroids. Discharged to home w/ HHC 11/9/22.   1. COVID-19 Pneumonia: exposed on 10/30/22; symptom onset 11/2/22 with mildly increased dyspnea and decreased appetite; tested positive on 11/2/22 at home x 3 tests and then again at wellness center on 11/4/22. Prescribed paxlovid on 11/4/22 bt pt refused to take it. Initially very reluctant to take higher doses of prednisone, then agreed with worsening respiratory status and more SOB on 11/7/22. Given decadron for 10 day course end date 11/16/22.  2. Advanced Emphysema with Chronic Hypoxic Respiratory Failure: On 4L O2 via NC at baseline and 5mg prednisone daily. Follows with Dr. (pulmonary) and recently started on spiriva and PRN lasix. At baseline O2 requirement on admit. Continued home regimen. 3. Abnormal CT: CTPE on admit showed new patchy irregular mass-like densities in lower lobes; likely inflammatory with enlarged mediastinal and bilateral hilar lymphadenopathy. Likely due to viral infection. Repeat CT in 1 month recommended to ensure resolution of infiltrates and lymphadenopathy. Discussed findings and follow up CT with patient extensively on admit; she stated she can get in with her pulmonologist to get repeat CT.  4. Elevated Troponin: 26 on admit, downtrended to 21. EKG nonacute. Likely due to above. No further testing indicated.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Hilar lymphadenopathy, Lung disorder, Lung infiltration, Lymphadenopathy mediastinal, Respiratory disorder
Clinical narrative: Clinical Summary Patient is a 82 y.o. female with a history of severe emphysema on home O2, anxiety, and dyslipidemia with recent positive COVID test on 11/2/22 who presented to hospital 11/6/2022 with 2-4 days of increased dyspnea and cough found to have COVID-19 Pneumonia. CTPE showed patchy irregular masslike densities in lower lobes; likely inflammatory with enlarged mediastinal and bilateral hilar lymphadenopathy. Improved with steroids. Discharged to home w/ HHC 11/9/22.   1. COVID-19 Pneumonia: exposed on 10/30/22; symptom onset 11/2/22 with mildly increased dyspnea and decreased appetite; tested positive on 11/2/22 at home x 3 tests and then again at wellness center on 11/4/22. Prescribed paxlovid on 11/4/22 bt pt refused to take it. Initially very reluctant to take higher doses of prednisone, then agreed with worsening respiratory status and more SOB on 11/7/22. Given decadron for 10 day course end date 11/16/22.  2. Advanced Emphysema with Chronic Hypoxic Respiratory Failure: On 4L O2 via NC at baseline and 5mg prednisone daily. Follows with Dr. (pulmonary) and recently started on spiriva and PRN lasix. At baseline O2 requirement on admit. Continued home regimen. 3. Abnormal CT: CTPE on admit showed new patchy irregular mass-like densities in lower lobes; likely inflammatory with enlarged mediastinal and bilateral hilar lymphadenopathy. Likely due to viral infection. Repeat CT in 1 month recommended to ensure resolution of infiltrates and lymphadenopathy. Discussed findings and follow up CT with patient extensively on admit; she stated she can get in with her pulmonologist to get repeat CT.  4. Elevated Troponin: 26 on admit, downtrended to 21. EKG nonacute. Likely due to above. No further testing indicated.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory failure, SARS-CoV-2 test positive, Troponin increased, Viral infection
Clinical narrative: Clinical Summary Patient is a 82 y.o. female with a history of severe emphysema on home O2, anxiety, and dyslipidemia with recent positive COVID test on 11/2/22 who presented to hospital 11/6/2022 with 2-4 days of increased dyspnea and cough found to have COVID-19 Pneumonia. CTPE showed patchy irregular masslike densities in lower lobes; likely inflammatory with enlarged mediastinal and bilateral hilar lymphadenopathy. Improved with steroids. Discharged to home w/ HHC 11/9/22.   1. COVID-19 Pneumonia: exposed on 10/30/22; symptom onset 11/2/22 with mildly increased dyspnea and decreased appetite; tested positive on 11/2/22 at home x 3 tests and then again at wellness center on 11/4/22. Prescribed paxlovid on 11/4/22 bt pt refused to take it. Initially very reluctant to take higher doses of prednisone, then agreed with worsening respiratory status and more SOB on 11/7/22. Given decadron for 10 day course end date 11/16/22.  2. Advanced Emphysema with Chronic Hypoxic Respiratory Failure: On 4L O2 via NC at baseline and 5mg prednisone daily. Follows with Dr. (pulmonary) and recently started on spiriva and PRN lasix. At baseline O2 requirement on admit. Continued home regimen. 3. Abnormal CT: CTPE on admit showed new patchy irregular mass-like densities in lower lobes; likely inflammatory with enlarged mediastinal and bilateral hilar lymphadenopathy. Likely due to viral infection. Repeat CT in 1 month recommended to ensure resolution of infiltrates and lymphadenopathy. Discussed findings and follow up CT with patient extensively on admit; she stated she can get in with her pulmonologist to get repeat CT.  4. Elevated Troponin: 26 on admit, downtrended to 21. EKG nonacute. Likely due to above. No further testing indicated.
Age: 68.0
Sex: F
Vaccine: FLUA4
Symptoms: Flushing, Hallucination, visual, Oedema peripheral
Clinical narrative: Nurse practitioner stated that patient had flushing and mild edema of arm and hand and that patient stated she was seeing things such a men, cats, and writing on her room walls, but knew the objects were not real
Age: 10.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, Pyrexia
Clinical narrative: Pfizer Bivalent COVID vaccine for 12+ given to 10 year old in error.   She had high fever the next day which was responsive to OTC antipyretics and went home from school.
Age: 31.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Circumstance or information capable of leading to medication error, Feeling abnormal, Malaise
Clinical narrative: I was pressured to get vaccinated under identity listed under patient information after I reported that that?s NOT my identity. The shelter was aware the entire time that I do not hold any status under that ID therefore it?s  attempting murder to insist I get vaccinated under someone else?s identification. On 4/24/21 and 4/29/21 immigration Officer confirmed my urgent notification to the shelter regarding my id that I do not hold ANY STATUS in this country at least I?m NOT respectively registered under id "private" DOB: Unknown and that?s considered at least immigration fraud. The shelter also had NO justification to hold as a client (Hostage) under ID that?s  not  even registered in Internal system. I?m NOT safe living here, being force to take drugs under a fake identification. I haven?t felt well or the same since taken the vaccine and since I?m unable to get assistance from police I reported my medical conditions to another authority on 9/28/22 and I still haven?t her back from any agency is against the law.
Age: 53.0
Sex: F
Vaccine: UNK
Symptoms: Herpes zoster, Rash
Clinical narrative: Had shingles symptoms starting on November 14th, gradually getting worse until I saw typical shingles rash on November 18.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Asthenia, Atrial fibrillation, Bladder cancer, Blood glucose abnormal
Clinical narrative: Patient is a 82 y.o. male patient of MD admitted to HCF on 11/9/22 due to complaints of chills and weakness.    Per Admission Information: Patient is a 82 y.o. year-old male, who presented with chills and falls.  The history was obtained from the database and validated with the patient.  He is a 82 y.o. male who presents with a chief complaint of Chills and Fall.  Patient presents emergency department for generalized weakness and multiple falls since Saturday around 5 days ago.  Patient notes that he has had 2 falls since then.  Patient notes that one of the falls he did hit his forehead.  He notes that fall was about 4 days ago.  Patient denies headache, dizziness, nausea, vomiting, numbness, tingling, unilateral extremity weakness.  Patient denies worsening or increased cough and congestion.  Patient's family is at bedside and notes that he has a chronic cough as well as chronic diarrhea at baseline which has been unchanged.  Patient has had multiple hospital stays over the last several months and was recently discharged from a different HCF.  They note that the patient has had a steady decline since being discharged from his skilled nursing facility.Family notes that the patient has had a "tremor and shaking all over his body".  Patient states that it is because he feels cold all the time and he is shivering.  Patient notes that he has had a decubitus ulcer to the left buttock.   Hospital Course: Patient diagnosed with COVID-19 infection upon admission to hospital. Initial CXR showed slightly improved aeration at the lung bases; bilateral interstitial opacity persists which could be mild edema or atypical infection. Patient required 2L of O2 via NC initially, but is now on RA, which is his baseline. Patient on isolation until 11/19/22. Patient treated with IV Rocephin and IV Decadron. Patient initially hypoglycemic as well. All oral diabetic medications stopped and patient placed on sensitive SSI. BG has since normalized. Patient will restart Farxiga per home instructions upon discharge. Appetite has improved. Initial UA demonstrated UTI. UC showed E. Coli positive. Not susceptible to cipro. Will transition to oral macrobid. Patient completed three days of IV Rocephin. He will complete four days of macrobid for total of 7 days on antibiotics. He is encouraged to follow-up with his provider at office, whom he sees for his prostate cancer. Coumadin resumed at home dose. To follow with PCP on Monday for re-check of PT/INR and additional coumadin dosing. Patient seen by care manager. Will go home with HHC.    Patient in stable condition at time of discharge. Discharge education provided. Patient to follow-up with PCP on Monday.    Discharge Diagnoses: 1. Persistent hypoglycemia in setting of DM type 2 2. COVID-19 3. Deconditioning 4. Falls, multiple 5. DPU left coccyx POA 6. Morbid obesity BMI 41.44 7. Chronic Afib 8. Urinary retention 9. UTI, E. Coli 10. Follows at PCP office for metastatic prostate cancer (mets to bone and lymph) as well as malignant neoplasm of dome of urinary bladder.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray abnormal, Chills, Condition aggravated, Culture urine positive
Clinical narrative: Patient is a 82 y.o. male patient of MD admitted to HCF on 11/9/22 due to complaints of chills and weakness.    Per Admission Information: Patient is a 82 y.o. year-old male, who presented with chills and falls.  The history was obtained from the database and validated with the patient.  He is a 82 y.o. male who presents with a chief complaint of Chills and Fall.  Patient presents emergency department for generalized weakness and multiple falls since Saturday around 5 days ago.  Patient notes that he has had 2 falls since then.  Patient notes that one of the falls he did hit his forehead.  He notes that fall was about 4 days ago.  Patient denies headache, dizziness, nausea, vomiting, numbness, tingling, unilateral extremity weakness.  Patient denies worsening or increased cough and congestion.  Patient's family is at bedside and notes that he has a chronic cough as well as chronic diarrhea at baseline which has been unchanged.  Patient has had multiple hospital stays over the last several months and was recently discharged from a different HCF.  They note that the patient has had a steady decline since being discharged from his skilled nursing facility.Family notes that the patient has had a "tremor and shaking all over his body".  Patient states that it is because he feels cold all the time and he is shivering.  Patient notes that he has had a decubitus ulcer to the left buttock.   Hospital Course: Patient diagnosed with COVID-19 infection upon admission to hospital. Initial CXR showed slightly improved aeration at the lung bases; bilateral interstitial opacity persists which could be mild edema or atypical infection. Patient required 2L of O2 via NC initially, but is now on RA, which is his baseline. Patient on isolation until 11/19/22. Patient treated with IV Rocephin and IV Decadron. Patient initially hypoglycemic as well. All oral diabetic medications stopped and patient placed on sensitive SSI. BG has since normalized. Patient will restart Farxiga per home instructions upon discharge. Appetite has improved. Initial UA demonstrated UTI. UC showed E. Coli positive. Not susceptible to cipro. Will transition to oral macrobid. Patient completed three days of IV Rocephin. He will complete four days of macrobid for total of 7 days on antibiotics. He is encouraged to follow-up with his provider at office, whom he sees for his prostate cancer. Coumadin resumed at home dose. To follow with PCP on Monday for re-check of PT/INR and additional coumadin dosing. Patient seen by care manager. Will go home with HHC.    Patient in stable condition at time of discharge. Discharge education provided. Patient to follow-up with PCP on Monday.    Discharge Diagnoses: 1. Persistent hypoglycemia in setting of DM type 2 2. COVID-19 3. Deconditioning 4. Falls, multiple 5. DPU left coccyx POA 6. Morbid obesity BMI 41.44 7. Chronic Afib 8. Urinary retention 9. UTI, E. Coli 10. Follows at PCP office for metastatic prostate cancer (mets to bone and lymph) as well as malignant neoplasm of dome of urinary bladder.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Decubitus ulcer, Escherichia test positive, Fall, Feeling cold, Head injury
Clinical narrative: Patient is a 82 y.o. male patient of MD admitted to HCF on 11/9/22 due to complaints of chills and weakness.    Per Admission Information: Patient is a 82 y.o. year-old male, who presented with chills and falls.  The history was obtained from the database and validated with the patient.  He is a 82 y.o. male who presents with a chief complaint of Chills and Fall.  Patient presents emergency department for generalized weakness and multiple falls since Saturday around 5 days ago.  Patient notes that he has had 2 falls since then.  Patient notes that one of the falls he did hit his forehead.  He notes that fall was about 4 days ago.  Patient denies headache, dizziness, nausea, vomiting, numbness, tingling, unilateral extremity weakness.  Patient denies worsening or increased cough and congestion.  Patient's family is at bedside and notes that he has a chronic cough as well as chronic diarrhea at baseline which has been unchanged.  Patient has had multiple hospital stays over the last several months and was recently discharged from a different HCF.  They note that the patient has had a steady decline since being discharged from his skilled nursing facility.Family notes that the patient has had a "tremor and shaking all over his body".  Patient states that it is because he feels cold all the time and he is shivering.  Patient notes that he has had a decubitus ulcer to the left buttock.   Hospital Course: Patient diagnosed with COVID-19 infection upon admission to hospital. Initial CXR showed slightly improved aeration at the lung bases; bilateral interstitial opacity persists which could be mild edema or atypical infection. Patient required 2L of O2 via NC initially, but is now on RA, which is his baseline. Patient on isolation until 11/19/22. Patient treated with IV Rocephin and IV Decadron. Patient initially hypoglycemic as well. All oral diabetic medications stopped and patient placed on sensitive SSI. BG has since normalized. Patient will restart Farxiga per home instructions upon discharge. Appetite has improved. Initial UA demonstrated UTI. UC showed E. Coli positive. Not susceptible to cipro. Will transition to oral macrobid. Patient completed three days of IV Rocephin. He will complete four days of macrobid for total of 7 days on antibiotics. He is encouraged to follow-up with his provider at office, whom he sees for his prostate cancer. Coumadin resumed at home dose. To follow with PCP on Monday for re-check of PT/INR and additional coumadin dosing. Patient seen by care manager. Will go home with HHC.    Patient in stable condition at time of discharge. Discharge education provided. Patient to follow-up with PCP on Monday.    Discharge Diagnoses: 1. Persistent hypoglycemia in setting of DM type 2 2. COVID-19 3. Deconditioning 4. Falls, multiple 5. DPU left coccyx POA 6. Morbid obesity BMI 41.44 7. Chronic Afib 8. Urinary retention 9. UTI, E. Coli 10. Follows at PCP office for metastatic prostate cancer (mets to bone and lymph) as well as malignant neoplasm of dome of urinary bladder.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoglycaemia, Lung opacity, Metastases to bone, Metastases to lymph nodes, Obesity
Clinical narrative: Patient is a 82 y.o. male patient of MD admitted to HCF on 11/9/22 due to complaints of chills and weakness.    Per Admission Information: Patient is a 82 y.o. year-old male, who presented with chills and falls.  The history was obtained from the database and validated with the patient.  He is a 82 y.o. male who presents with a chief complaint of Chills and Fall.  Patient presents emergency department for generalized weakness and multiple falls since Saturday around 5 days ago.  Patient notes that he has had 2 falls since then.  Patient notes that one of the falls he did hit his forehead.  He notes that fall was about 4 days ago.  Patient denies headache, dizziness, nausea, vomiting, numbness, tingling, unilateral extremity weakness.  Patient denies worsening or increased cough and congestion.  Patient's family is at bedside and notes that he has a chronic cough as well as chronic diarrhea at baseline which has been unchanged.  Patient has had multiple hospital stays over the last several months and was recently discharged from a different HCF.  They note that the patient has had a steady decline since being discharged from his skilled nursing facility.Family notes that the patient has had a "tremor and shaking all over his body".  Patient states that it is because he feels cold all the time and he is shivering.  Patient notes that he has had a decubitus ulcer to the left buttock.   Hospital Course: Patient diagnosed with COVID-19 infection upon admission to hospital. Initial CXR showed slightly improved aeration at the lung bases; bilateral interstitial opacity persists which could be mild edema or atypical infection. Patient required 2L of O2 via NC initially, but is now on RA, which is his baseline. Patient on isolation until 11/19/22. Patient treated with IV Rocephin and IV Decadron. Patient initially hypoglycemic as well. All oral diabetic medications stopped and patient placed on sensitive SSI. BG has since normalized. Patient will restart Farxiga per home instructions upon discharge. Appetite has improved. Initial UA demonstrated UTI. UC showed E. Coli positive. Not susceptible to cipro. Will transition to oral macrobid. Patient completed three days of IV Rocephin. He will complete four days of macrobid for total of 7 days on antibiotics. He is encouraged to follow-up with his provider at office, whom he sees for his prostate cancer. Coumadin resumed at home dose. To follow with PCP on Monday for re-check of PT/INR and additional coumadin dosing. Patient seen by care manager. Will go home with HHC.    Patient in stable condition at time of discharge. Discharge education provided. Patient to follow-up with PCP on Monday.    Discharge Diagnoses: 1. Persistent hypoglycemia in setting of DM type 2 2. COVID-19 3. Deconditioning 4. Falls, multiple 5. DPU left coccyx POA 6. Morbid obesity BMI 41.44 7. Chronic Afib 8. Urinary retention 9. UTI, E. Coli 10. Follows at PCP office for metastatic prostate cancer (mets to bone and lymph) as well as malignant neoplasm of dome of urinary bladder.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Urine analysis abnormal
Clinical narrative: Patient is a 82 y.o. male patient of MD admitted to HCF on 11/9/22 due to complaints of chills and weakness.    Per Admission Information: Patient is a 82 y.o. year-old male, who presented with chills and falls.  The history was obtained from the database and validated with the patient.  He is a 82 y.o. male who presents with a chief complaint of Chills and Fall.  Patient presents emergency department for generalized weakness and multiple falls since Saturday around 5 days ago.  Patient notes that he has had 2 falls since then.  Patient notes that one of the falls he did hit his forehead.  He notes that fall was about 4 days ago.  Patient denies headache, dizziness, nausea, vomiting, numbness, tingling, unilateral extremity weakness.  Patient denies worsening or increased cough and congestion.  Patient's family is at bedside and notes that he has a chronic cough as well as chronic diarrhea at baseline which has been unchanged.  Patient has had multiple hospital stays over the last several months and was recently discharged from a different HCF.  They note that the patient has had a steady decline since being discharged from his skilled nursing facility.Family notes that the patient has had a "tremor and shaking all over his body".  Patient states that it is because he feels cold all the time and he is shivering.  Patient notes that he has had a decubitus ulcer to the left buttock.   Hospital Course: Patient diagnosed with COVID-19 infection upon admission to hospital. Initial CXR showed slightly improved aeration at the lung bases; bilateral interstitial opacity persists which could be mild edema or atypical infection. Patient required 2L of O2 via NC initially, but is now on RA, which is his baseline. Patient on isolation until 11/19/22. Patient treated with IV Rocephin and IV Decadron. Patient initially hypoglycemic as well. All oral diabetic medications stopped and patient placed on sensitive SSI. BG has since normalized. Patient will restart Farxiga per home instructions upon discharge. Appetite has improved. Initial UA demonstrated UTI. UC showed E. Coli positive. Not susceptible to cipro. Will transition to oral macrobid. Patient completed three days of IV Rocephin. He will complete four days of macrobid for total of 7 days on antibiotics. He is encouraged to follow-up with his provider at office, whom he sees for his prostate cancer. Coumadin resumed at home dose. To follow with PCP on Monday for re-check of PT/INR and additional coumadin dosing. Patient seen by care manager. Will go home with HHC.    Patient in stable condition at time of discharge. Discharge education provided. Patient to follow-up with PCP on Monday.    Discharge Diagnoses: 1. Persistent hypoglycemia in setting of DM type 2 2. COVID-19 3. Deconditioning 4. Falls, multiple 5. DPU left coccyx POA 6. Morbid obesity BMI 41.44 7. Chronic Afib 8. Urinary retention 9. UTI, E. Coli 10. Follows at PCP office for metastatic prostate cancer (mets to bone and lymph) as well as malignant neoplasm of dome of urinary bladder.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Bursitis, Injection site inflammation, Injection site pain, Magnetic resonance imaging
Clinical narrative: The covid vaccine was fine. I received my FLU SHOT at the same time but in right arm which is my dominant side.  The injection hurt at time she gave it and within just a few hours got worse. Within 2 days my entire shoulder and all muscles in my arm were severely painful. Although I iced and heated the affected arm, ended up at my doctor on 10/25/2022 at which time she said it was all inflamed. Gave me trigger point injections around scapula and said she suspected deltoid bursitis. It has only gotten worse. I will be getting an MRI of my shoulder 11/23 and depending on what that shows, will either see an orthopedist on 12/6 or see my pain management physician.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rash, Rash erythematous, Rash papular, Rash pruritic
Clinical narrative: Patient developed rash on arms starting about 1 hour post-vaccination. Described rash as really red, bumpy, and slightly itchy; worse on right arm (vaccinated arm). Self-treated with benadryl.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, COVID-19, Chest X-ray abnormal, Chronic fatigue syndrome, Chronic kidney disease
Clinical narrative: Patient is a 60 y.o. female patient of local CNP with history of history of COPD, chronic hypoxemic respiratory failure, CHF, GERD, CAD, HTN, HLD, PUD, c who presented to the emergency department with shortness of breath, found to have COPD exacerbation, hypoxemia and hypokalemia   Acute exacerbation of COPD Acute on chronic hypoxemic respiratory failure: Chest x-ray past reviewed, hyperinflated lung, no airspace disease, radiology read noted bronchitis without pneumonia or edema IV then p.o. steroids, Symbicort twice daily, Spiriva, DuoNebs every 4 hours Levaquin Initially on BiPAP Currently at baseline she is on 2 L nasal cannula   Covid-19 Virus Infection Date of onset of symptoms: Shortness of breath Symptoms present on admission: Yes Date of covid positive test: 11/1/2022 Vaccination status: vaccinated Imaging: CXR no infiltrate Oxygen requirements on admission: BIPAP Current oxygen requirements: 2 L of oxygen through nasal cannula Medical therapy: remdesivir and steroids Consultants following: ID  Anticipated special isolation end date: 11/10/22 Follow inflammatory markers     Hypokalemia, severe, present on admission, improving Replete aggressively p.o. potassium Electrolyte replacement protocol BMP daily   NIDDM2 w/ hyperglycemia and peripheral neuropathy: Continue home gabapentin Holding glipizide Diabetic diet and insulin sliding scale  Lantus insulin during hospitalization secondary to IV steroids then resume glipizide on discharge.  CAD: Chronic chronic diastolic CHF: Essential HTN: proBNP 285 the time presentation Chest x-ray not consistent with pulmonary edema Guideline directed medical therapy Lasix 20 mg daily Toprol, Imdur, Aldactone   PUD: GERD: pantoprazole and sucralfate   HLD: Atorvastatin   Obesity, BMI 30.79, due to excess calories, with serious comorbidity: Encourage diet modification, active lifestyle, and weight reduction.   Chronic fatigue syndrome Physical deconditioning PT OT and social service consulted for discharge plan Home health care  We discharge patient home with home of care after improvement of his general condition and shortness of breath.  Patient to follow-up with PCP in 1 week.  Follow-up with pulmonary and ID as noted.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Dyspnoea, Essential hypertension, Hyperglycaemia
Clinical narrative: Patient is a 60 y.o. female patient of local CNP with history of history of COPD, chronic hypoxemic respiratory failure, CHF, GERD, CAD, HTN, HLD, PUD, c who presented to the emergency department with shortness of breath, found to have COPD exacerbation, hypoxemia and hypokalemia   Acute exacerbation of COPD Acute on chronic hypoxemic respiratory failure: Chest x-ray past reviewed, hyperinflated lung, no airspace disease, radiology read noted bronchitis without pneumonia or edema IV then p.o. steroids, Symbicort twice daily, Spiriva, DuoNebs every 4 hours Levaquin Initially on BiPAP Currently at baseline she is on 2 L nasal cannula   Covid-19 Virus Infection Date of onset of symptoms: Shortness of breath Symptoms present on admission: Yes Date of covid positive test: 11/1/2022 Vaccination status: vaccinated Imaging: CXR no infiltrate Oxygen requirements on admission: BIPAP Current oxygen requirements: 2 L of oxygen through nasal cannula Medical therapy: remdesivir and steroids Consultants following: ID  Anticipated special isolation end date: 11/10/22 Follow inflammatory markers     Hypokalemia, severe, present on admission, improving Replete aggressively p.o. potassium Electrolyte replacement protocol BMP daily   NIDDM2 w/ hyperglycemia and peripheral neuropathy: Continue home gabapentin Holding glipizide Diabetic diet and insulin sliding scale  Lantus insulin during hospitalization secondary to IV steroids then resume glipizide on discharge.  CAD: Chronic chronic diastolic CHF: Essential HTN: proBNP 285 the time presentation Chest x-ray not consistent with pulmonary edema Guideline directed medical therapy Lasix 20 mg daily Toprol, Imdur, Aldactone   PUD: GERD: pantoprazole and sucralfate   HLD: Atorvastatin   Obesity, BMI 30.79, due to excess calories, with serious comorbidity: Encourage diet modification, active lifestyle, and weight reduction.   Chronic fatigue syndrome Physical deconditioning PT OT and social service consulted for discharge plan Home health care  We discharge patient home with home of care after improvement of his general condition and shortness of breath.  Patient to follow-up with PCP in 1 week.  Follow-up with pulmonary and ID as noted.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Hypokalaemia, Hypoxia, Lung hyperinflation, N-terminal prohormone brain natriuretic peptide increased, Neuropathy peripheral
Clinical narrative: Patient is a 60 y.o. female patient of local CNP with history of history of COPD, chronic hypoxemic respiratory failure, CHF, GERD, CAD, HTN, HLD, PUD, c who presented to the emergency department with shortness of breath, found to have COPD exacerbation, hypoxemia and hypokalemia   Acute exacerbation of COPD Acute on chronic hypoxemic respiratory failure: Chest x-ray past reviewed, hyperinflated lung, no airspace disease, radiology read noted bronchitis without pneumonia or edema IV then p.o. steroids, Symbicort twice daily, Spiriva, DuoNebs every 4 hours Levaquin Initially on BiPAP Currently at baseline she is on 2 L nasal cannula   Covid-19 Virus Infection Date of onset of symptoms: Shortness of breath Symptoms present on admission: Yes Date of covid positive test: 11/1/2022 Vaccination status: vaccinated Imaging: CXR no infiltrate Oxygen requirements on admission: BIPAP Current oxygen requirements: 2 L of oxygen through nasal cannula Medical therapy: remdesivir and steroids Consultants following: ID  Anticipated special isolation end date: 11/10/22 Follow inflammatory markers     Hypokalemia, severe, present on admission, improving Replete aggressively p.o. potassium Electrolyte replacement protocol BMP daily   NIDDM2 w/ hyperglycemia and peripheral neuropathy: Continue home gabapentin Holding glipizide Diabetic diet and insulin sliding scale  Lantus insulin during hospitalization secondary to IV steroids then resume glipizide on discharge.  CAD: Chronic chronic diastolic CHF: Essential HTN: proBNP 285 the time presentation Chest x-ray not consistent with pulmonary edema Guideline directed medical therapy Lasix 20 mg daily Toprol, Imdur, Aldactone   PUD: GERD: pantoprazole and sucralfate   HLD: Atorvastatin   Obesity, BMI 30.79, due to excess calories, with serious comorbidity: Encourage diet modification, active lifestyle, and weight reduction.   Chronic fatigue syndrome Physical deconditioning PT OT and social service consulted for discharge plan Home health care  We discharge patient home with home of care after improvement of his general condition and shortness of breath.  Patient to follow-up with PCP in 1 week.  Follow-up with pulmonary and ID as noted.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Obesity, Physical deconditioning, Positive airway pressure therapy, Respiratory failure, Type 2 diabetes mellitus
Clinical narrative: Patient is a 60 y.o. female patient of local CNP with history of history of COPD, chronic hypoxemic respiratory failure, CHF, GERD, CAD, HTN, HLD, PUD, c who presented to the emergency department with shortness of breath, found to have COPD exacerbation, hypoxemia and hypokalemia   Acute exacerbation of COPD Acute on chronic hypoxemic respiratory failure: Chest x-ray past reviewed, hyperinflated lung, no airspace disease, radiology read noted bronchitis without pneumonia or edema IV then p.o. steroids, Symbicort twice daily, Spiriva, DuoNebs every 4 hours Levaquin Initially on BiPAP Currently at baseline she is on 2 L nasal cannula   Covid-19 Virus Infection Date of onset of symptoms: Shortness of breath Symptoms present on admission: Yes Date of covid positive test: 11/1/2022 Vaccination status: vaccinated Imaging: CXR no infiltrate Oxygen requirements on admission: BIPAP Current oxygen requirements: 2 L of oxygen through nasal cannula Medical therapy: remdesivir and steroids Consultants following: ID  Anticipated special isolation end date: 11/10/22 Follow inflammatory markers     Hypokalemia, severe, present on admission, improving Replete aggressively p.o. potassium Electrolyte replacement protocol BMP daily   NIDDM2 w/ hyperglycemia and peripheral neuropathy: Continue home gabapentin Holding glipizide Diabetic diet and insulin sliding scale  Lantus insulin during hospitalization secondary to IV steroids then resume glipizide on discharge.  CAD: Chronic chronic diastolic CHF: Essential HTN: proBNP 285 the time presentation Chest x-ray not consistent with pulmonary edema Guideline directed medical therapy Lasix 20 mg daily Toprol, Imdur, Aldactone   PUD: GERD: pantoprazole and sucralfate   HLD: Atorvastatin   Obesity, BMI 30.79, due to excess calories, with serious comorbidity: Encourage diet modification, active lifestyle, and weight reduction.   Chronic fatigue syndrome Physical deconditioning PT OT and social service consulted for discharge plan Home health care  We discharge patient home with home of care after improvement of his general condition and shortness of breath.  Patient to follow-up with PCP in 1 week.  Follow-up with pulmonary and ID as noted.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, Blood glucose increased, COVID-19, Cerebral venous sinus thrombosis
Clinical narrative: Patient is a 67 y.o. female patient with history of CHF, diabetes, GERD, hypertension, and stroke who presented to Doctors Hospital with generalized weakness.   Covid-19 Virus Infection Acute respiratory failure with hypoxia Date of onset of symptoms: Patient not sure Symptoms present on admission: Fever, shortness of breath, weakness, cough Date of covid positive test: 11/2/2022 Vaccination status: vaccinated Imaging: Chest x-ray negative, pacemaker in good position Oxygen requirements on admission: 1 L nasal cannula, placed on2 lit ovrnight. Wean as tolerated Continue Decadron, Vitamin C, Vitamin D, Zinc, Pepcid, and Loratadine Albuterol inhaler, Incentive Spirometry, and Continuous Pulse Oximetry   Special Precautions      Generalized weakness Fatigue Likely in the setting of COVID CT head negative, brain atrophy and chronic microvascular ischemic changes stable Pt seen by PT/OT. Recommending 5 days therapy, however doing better this am PT to reevaluate   Elevated troponin Troponin 20 > 21 EKG negative for acute ischemic changes     Essential hypertension Continue home amlodipine and Coreg Uncontrolled, will increase home dose   History of stroke Cerebral venous sinus thrombosis Found in 9/2021 Continue Eliquis and atorvastatin Diabetes mellitus, type II, non-insulin-dependent Hemoglobin A1c 10 Glucose 351 SSI and glucose checks   Hypothyroidism Continue home Synthroid   GERD Continue home PPI   Depression Continue home fluoxetine
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Computerised tomogram head normal, Condition aggravated, Cough, Depression
Clinical narrative: Patient is a 67 y.o. female patient with history of CHF, diabetes, GERD, hypertension, and stroke who presented to Doctors Hospital with generalized weakness.   Covid-19 Virus Infection Acute respiratory failure with hypoxia Date of onset of symptoms: Patient not sure Symptoms present on admission: Fever, shortness of breath, weakness, cough Date of covid positive test: 11/2/2022 Vaccination status: vaccinated Imaging: Chest x-ray negative, pacemaker in good position Oxygen requirements on admission: 1 L nasal cannula, placed on2 lit ovrnight. Wean as tolerated Continue Decadron, Vitamin C, Vitamin D, Zinc, Pepcid, and Loratadine Albuterol inhaler, Incentive Spirometry, and Continuous Pulse Oximetry   Special Precautions      Generalized weakness Fatigue Likely in the setting of COVID CT head negative, brain atrophy and chronic microvascular ischemic changes stable Pt seen by PT/OT. Recommending 5 days therapy, however doing better this am PT to reevaluate   Elevated troponin Troponin 20 > 21 EKG negative for acute ischemic changes     Essential hypertension Continue home amlodipine and Coreg Uncontrolled, will increase home dose   History of stroke Cerebral venous sinus thrombosis Found in 9/2021 Continue Eliquis and atorvastatin Diabetes mellitus, type II, non-insulin-dependent Hemoglobin A1c 10 Glucose 351 SSI and glucose checks   Hypothyroidism Continue home Synthroid   GERD Continue home PPI   Depression Continue home fluoxetine
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram normal, Fatigue, Gastrooesophageal reflux disease, Glycosylated haemoglobin increased
Clinical narrative: Patient is a 67 y.o. female patient with history of CHF, diabetes, GERD, hypertension, and stroke who presented to Doctors Hospital with generalized weakness.   Covid-19 Virus Infection Acute respiratory failure with hypoxia Date of onset of symptoms: Patient not sure Symptoms present on admission: Fever, shortness of breath, weakness, cough Date of covid positive test: 11/2/2022 Vaccination status: vaccinated Imaging: Chest x-ray negative, pacemaker in good position Oxygen requirements on admission: 1 L nasal cannula, placed on2 lit ovrnight. Wean as tolerated Continue Decadron, Vitamin C, Vitamin D, Zinc, Pepcid, and Loratadine Albuterol inhaler, Incentive Spirometry, and Continuous Pulse Oximetry   Special Precautions      Generalized weakness Fatigue Likely in the setting of COVID CT head negative, brain atrophy and chronic microvascular ischemic changes stable Pt seen by PT/OT. Recommending 5 days therapy, however doing better this am PT to reevaluate   Elevated troponin Troponin 20 > 21 EKG negative for acute ischemic changes     Essential hypertension Continue home amlodipine and Coreg Uncontrolled, will increase home dose   History of stroke Cerebral venous sinus thrombosis Found in 9/2021 Continue Eliquis and atorvastatin Diabetes mellitus, type II, non-insulin-dependent Hemoglobin A1c 10 Glucose 351 SSI and glucose checks   Hypothyroidism Continue home Synthroid   GERD Continue home PPI   Depression Continue home fluoxetine
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Hypothyroidism, Pyrexia, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: Patient is a 67 y.o. female patient with history of CHF, diabetes, GERD, hypertension, and stroke who presented to Doctors Hospital with generalized weakness.   Covid-19 Virus Infection Acute respiratory failure with hypoxia Date of onset of symptoms: Patient not sure Symptoms present on admission: Fever, shortness of breath, weakness, cough Date of covid positive test: 11/2/2022 Vaccination status: vaccinated Imaging: Chest x-ray negative, pacemaker in good position Oxygen requirements on admission: 1 L nasal cannula, placed on2 lit ovrnight. Wean as tolerated Continue Decadron, Vitamin C, Vitamin D, Zinc, Pepcid, and Loratadine Albuterol inhaler, Incentive Spirometry, and Continuous Pulse Oximetry   Special Precautions      Generalized weakness Fatigue Likely in the setting of COVID CT head negative, brain atrophy and chronic microvascular ischemic changes stable Pt seen by PT/OT. Recommending 5 days therapy, however doing better this am PT to reevaluate   Elevated troponin Troponin 20 > 21 EKG negative for acute ischemic changes     Essential hypertension Continue home amlodipine and Coreg Uncontrolled, will increase home dose   History of stroke Cerebral venous sinus thrombosis Found in 9/2021 Continue Eliquis and atorvastatin Diabetes mellitus, type II, non-insulin-dependent Hemoglobin A1c 10 Glucose 351 SSI and glucose checks   Hypothyroidism Continue home Synthroid   GERD Continue home PPI   Depression Continue home fluoxetine
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Type 2 diabetes mellitus
Clinical narrative: Patient is a 67 y.o. female patient with history of CHF, diabetes, GERD, hypertension, and stroke who presented to Doctors Hospital with generalized weakness.   Covid-19 Virus Infection Acute respiratory failure with hypoxia Date of onset of symptoms: Patient not sure Symptoms present on admission: Fever, shortness of breath, weakness, cough Date of covid positive test: 11/2/2022 Vaccination status: vaccinated Imaging: Chest x-ray negative, pacemaker in good position Oxygen requirements on admission: 1 L nasal cannula, placed on2 lit ovrnight. Wean as tolerated Continue Decadron, Vitamin C, Vitamin D, Zinc, Pepcid, and Loratadine Albuterol inhaler, Incentive Spirometry, and Continuous Pulse Oximetry   Special Precautions      Generalized weakness Fatigue Likely in the setting of COVID CT head negative, brain atrophy and chronic microvascular ischemic changes stable Pt seen by PT/OT. Recommending 5 days therapy, however doing better this am PT to reevaluate   Elevated troponin Troponin 20 > 21 EKG negative for acute ischemic changes     Essential hypertension Continue home amlodipine and Coreg Uncontrolled, will increase home dose   History of stroke Cerebral venous sinus thrombosis Found in 9/2021 Continue Eliquis and atorvastatin Diabetes mellitus, type II, non-insulin-dependent Hemoglobin A1c 10 Glucose 351 SSI and glucose checks   Hypothyroidism Continue home Synthroid   GERD Continue home PPI   Depression Continue home fluoxetine
Age: 80.0
Sex: F
Vaccine: COVID19-2, FLUA4
Symptoms: Incorrect dose administered, Injury associated with device, Intercepted product selection error
Clinical narrative: The patient only wanted to get the Moderna Bivalent booster vaccination, but I accidentally typed up the vaccine for a flu shot and I inserted the needle of the flu shot into the patient. However, I was talking with the patient during the administration, and she was talking about a "series" of vaccines, which helped me realize that I had made a mistake. Luckily, I realized the mistake before I started injecting the flu shot medication into the patient. I removed the needle from the patient's arm, I informed her of my mistake, and I showed her that the vaccine liquid was still located inside the barrel of the syringe. I then proceeded to give her the correct vaccine (The Moderna).
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cardiac arrest, Death, Housebound, SARS-CoV-2 test positive
Clinical narrative: Home bound 660+ # patient chronically ill with conditions listed elsewhere including Lupus vs. undifferentiated connective tissue disease on Hydroxychloroquine;  COVID vaccines: J+J given 4/7/21; Moderna booster given 11/19/21;  COVID infection 4/17/2022;  Took Molnupiravir and she was recovering at home - EMS visit on 5/1/2022 with cardiac arrest and death.
Age: 57.0
Sex: M
Vaccine: COVID19-2
Symptoms: Injection site discomfort, Injection site mass
Clinical narrative: Patient came in with a quarter sized lump on his arm where the vaccine was given. He stated that it only caused discomfort when he pressed on it.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Computerised tomogram, Electrocardiogram, Pericarditis
Clinical narrative: Pericarditis
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram cerebral normal, Aphasia, Arteriogram carotid normal, Asthenia, Atrial fibrillation
Clinical narrative: Clinical Summary Patient is a 75 y.o. male with a history of Migraines, Afib and Cerebral amyloid angiopathy with associated cognitive decline who presented to RMH 10/22/2022 with acute worsening of confusion, expressive aphasia and generalized weakness found to have nonacute CT head and CTA H/N and COVID positive   1. Acute on chronic metabolic encephalopathy: with chronic vascular/amyloid dementia - precipitated by likely COVID. At baseline Oriented x 2. MRI brain - limited study 10/22/22 showed no acute infarct.  EEG with no epileptiform activity. Improved.  2. COVID 19: diagnosed 10/22/22 with wife being recently positive. Asymptomatic except as above and on room air. Isolation through 11/2/22 per infection control. 3. Afib RVR: Known history, not on AC due to amyloid. Continued ASA. Previously on BB - but stopped as HR controlled and soft BP. Restarted BB 10/23.  HR controlled
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Computerised tomogram head normal, Confusional state, Electroencephalogram normal, Magnetic resonance imaging head normal
Clinical narrative: Clinical Summary Patient is a 75 y.o. male with a history of Migraines, Afib and Cerebral amyloid angiopathy with associated cognitive decline who presented to RMH 10/22/2022 with acute worsening of confusion, expressive aphasia and generalized weakness found to have nonacute CT head and CTA H/N and COVID positive   1. Acute on chronic metabolic encephalopathy: with chronic vascular/amyloid dementia - precipitated by likely COVID. At baseline Oriented x 2. MRI brain - limited study 10/22/22 showed no acute infarct.  EEG with no epileptiform activity. Improved.  2. COVID 19: diagnosed 10/22/22 with wife being recently positive. Asymptomatic except as above and on room air. Isolation through 11/2/22 per infection control. 3. Afib RVR: Known history, not on AC due to amyloid. Continued ASA. Previously on BB - but stopped as HR controlled and soft BP. Restarted BB 10/23.  HR controlled